Raring to go

The Neuro’s Clinical Research Unit is leading the push to find treatments for the rare diseases that research has left behind    By Sophie Lorenzo and Shawn Hayward...
February 26, 2021

Zooming in on nanomedicine’s ‘crown’

Dr. Sara Sheibani, an affiliated academic member at Department of Anatomy and Cell Biology, and Dr. Kaustuv Basu, staff scientist at the Facility...
February 25, 2021

Viruses can ‘hijack’ cellular process to block immune response

Discovery could lead to future treatments for viral infections Source: McGill Newsroom Research led by McGill University and Queen’s University Belfast has found...
February 17, 2021

Biodiversity is its own catalyst – to a point

Study sheds light on how microbiomes might recover from biodiversity loss Source: McGill Newsroom For decades, scientists have wrestled with rival theories to...
February 10, 2021

When is dead really dead?

The death prediction and physiology after removal of therapy study (DePPaRT study) Dr. Sam Shemie, Professor in the Department of Pediatrics at McGill...
February 4, 2021

New data from ACCESS Open Minds mental health care initiative shows how to reduce wait times and provide quality care for more Canadian youth

Paradigms are shifting in youth mental health care in Canada Source: ACCESS Open Minds JANUARY 28, 2021, MONTREAL, QUE. — ACCESS Open Minds...
February 4, 2021

Major European grant backs McGill research on rare condition

Source: Research and Innovation Office The European Joint Programme on Rare Diseases (EJP RD) has granted 1.6 million euros in support of an...
February 4, 2021

McGill researchers receive grants from Arthritis Society

“These researchers and these projects hold great promise for the future of arthritis diagnosis, care and prevention" By Media Relations Office Dr. Lisbet...
February 4, 2021

LSD may offer viable treatment for certain mental disorders

McGill study a step in understanding the mechanism of psychedelics’ impact on brain and potential for therapeutic use  Researchers from McGill University have...
January 27, 2021

New study of hydroxychloroquine usage may help personalize lupus treatment

RI-MUHC researchers identify factors associated with poor outcomes for lupus patients Source: RI-MUHC Lupus has been called the “disease with a thousand faces,”...
January 26, 2021

McGill study aims to measure effectiveness of HPV vaccine

The ongoing TRAP-HPV (Transmission Reduction and Prevention with HPV vaccination) study aims to determine the efficacy of the Human papillomavirus (HPV) vaccine Gardasil...
January 26, 2021

Overcoming vaccine hesitancy

By Ian Popple After achieving the monumental feat of developing and approving, not one, but two COVID-19 vaccines in under a year, the...
January 26, 2021